Gemini Pharmaceuticals specializes in research, development, manufacturing of OTC drugs, Nutritionals, veterinary and pet supplements.
| Website | http://www.geminipharm.com |
| Revenue | $76 million |
| Funding | $2 million |
| Employees | 51 (51 on RocketReach) |
| Address | 87 Modular Ave, Commack, New York 11725, US |
| Phone | +1 718-384-7334 |
| Industry | Pharmaceuticals, Healthcare |
| Keywords | Otc Drugs, Pharmaceutical Research, Drug Development, Drug Manufacturing, Veterinary Supplements, Pet Supplements, Health Supplements, Animal Health, Pharmaceutical Manufacturing, Over The Counter Medication, Nutritional Products, Pet Health Products, Vitamin Supplements, Healthcare Products, Health And Wellness, Animal Nutrition, Medicine, Supplements |
| Competitors | Teva Pharmaceuticals, Mylan Belgium, Sandoz, Amgen, Bristol Myers Squibb, Pfizer, AbbVie, Roche, Gilead Sciences, GSK +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Gemini Pharmaceuticals employee's phone or email?
The Gemini Pharmaceuticals annual revenue was $76 million in 2026.
Mike Finamore is the CEO of Gemini Pharmaceuticals.
51 people are employed at Gemini Pharmaceuticals.
Gemini Pharmaceuticals is based in Commack, New York.
The NAICS codes for Gemini Pharmaceuticals are [32, 32541, 3254, 325].
The SIC codes for Gemini Pharmaceuticals are [283, 28].